Zepbound™ and the Ivím weight loss program

When combined with a reduced calorie diet and increased physical activity, Zepbound™, a weekly tirzepatide injection, can help you lose weight, curb hunger, and regulate blood sugar.*

*Disclaimer: Zepbound™ may be prescribed by an Ivím provider if deemed appropriate for your medical needs. For additional safety information, please see our Safety Page.

Zepbound™ (tirzepatide) injection is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for the treatment of type 2 diabetes. It functions by mimicking a hormone that targets areas of the brain involved in appetite regulation.

Zepbound™ works by slowing gastric emptying, enhancing feelings of fullness, and reducing appetite, which can help manage weight when combined with diet and exercise.

Coverage depends on your insurance plan and whether Zepbound™ is prescribed for an FDA-approved use. Ivím Health offers a free initial consultation to navigate insurance or explore self-pay options.

Zepbound™ is FDA approved for some adults who are overweight with other weight-related medical problems, to help them lose excess body weight and keep the weight off and may be prescribed by an Ivím Health provider as part of your weight management program.

Choosing a GLP-1 medication like Zepbound™ depends on individual health history and insurance coverage. Your Ivím provider can help determine the best option for your weight loss journey.

*Disclaimer: Zepbound™ is a registered trademark of Eli Lilly. Ivím is not affiliated with Eli Lilly.